| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |